<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01290666</url>
  </required_header>
  <id_info>
    <org_study_id>CS157</org_study_id>
    <nct_id>NCT01290666</nct_id>
  </id_info>
  <brief_title>Study of GORE® BIO-A® Fistula Plug for Use in Anal Fistula Repair</brief_title>
  <official_title>Multicenter,Prospective, Observational Study of GORE® BIO-A® Fistula Plug for Use in Anal Fistula Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>W.L.Gore &amp; Associates</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>W.L.Gore &amp; Associates</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary outcome variable is healing at the final follow up visit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary purpose of this prospective, multicenter, observational, single arm study is to
      further substantiate efficacy of the GORE® BIO-A® Fistula Plug when used as a soft tissue
      reinforcement of anal fistula repair and healing.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Sufficient patient population achieved; decision not due to product complaints.
  </why_stopped>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fistula Closure</measure>
    <time_frame>12 months post procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of Drainage Post Procedure</measure>
    <time_frame>Follow up out to 12 months post procedure</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">93</enrollment>
  <condition>Anal Fistula</condition>
  <arm_group>
    <arm_group_label>GORE® BIO-A® Fistula Plug</arm_group_label>
    <description>All patients in study receive the GORE® BIO-A® Fistula Plug.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fistula Plug</intervention_name>
    <description>Bioabsorbable fistula plug</description>
    <arm_group_label>GORE® BIO-A® Fistula Plug</arm_group_label>
    <other_name>GORE® BIO-A® Fistula Plug</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients presenting with anal fistulae that meet inclusion and exclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Transsphincteric fistula consisting of 1 tract(defined as a fistula which would not be
             amenable to fistulotomy); determined during operative procedure

          -  Likely cryptoglandular origin

          -  Must be at least 18 years of age

          -  Patients informed about the study, and will have read, understood and signed the
             patient informed consent and authorization to use PHI data, as applicable

          -  Patients willing and able to submit to postoperative follow-up evaluations

        Exclusion Criteria:

          -  Crohn's Disease

          -  Evidence of on-going local infection

          -  History of more than 2 prior definitive repair attempts; repair attempt is defined as
             any of the following: advancement flap, cutting seton, fistulotomy, fistulectomy,
             fibrin glue, anal fistula plug, LIFT

          -  Superficial fistulas without any muscle involvement

          -  Fistulae of traumatic origin, including obstetric

          -  Intersphincteric fistulas that would be candidate for fistulotomy

          -  Horseshoe or multi-tract fistulas

          -  Ano-vaginal or recto-vaginal fistulas

          -  Anastomotic fistulas (ileo-anal, colo-anal)

          -  A wound-healing or autoimmune disorder (including insulin-dependent diabetics)

          -  Subjects who are immunocompromised such as, with HIV, or currently receiving chemo or
             radiation therapy

          -  Subjects who are immunosuppressed, e.g. transplant patients, patients taking steroids,
             TNF agents, methotrexate

          -  History of prior or current pelvic radiation

          -  Difficulty comprehending or complying with the study (in surgeon's opinion)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael J Stamos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Irvine</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2011</study_first_submitted>
  <study_first_submitted_qc>February 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2011</study_first_posted>
  <results_first_submitted>November 9, 2015</results_first_submitted>
  <results_first_submitted_qc>November 15, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 13, 2017</results_first_posted>
  <last_update_submitted>November 15, 2016</last_update_submitted>
  <last_update_submitted_qc>November 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Rectal Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A total of 93 subjects were recruited from 11 sites between March of 2011 and September 2013.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>GORE® BIO-A® Fistula Plug</title>
          <description>All patients in study receive the GORE® BIO-A® Fistula Plug.
Fistula Plug: Bioabsorbable fistula plug</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="93"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="38"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Early Termination of Study</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>GORE® BIO-A® Fistula Plug</title>
          <description>All patients in study receive the GORE® BIO-A® Fistula Plug.
Fistula Plug: Bioabsorbable fistula plug</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="93"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fistula Closure</title>
        <time_frame>12 months post procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GORE® BIO-A® Fistula Plug</title>
            <description>All patients in study receive the GORE® BIO-A® Fistula Plug.
Fistula Plug: Bioabsorbable fistula plug</description>
          </group>
        </group_list>
        <measure>
          <title>Fistula Closure</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Drainage Post Procedure</title>
        <time_frame>Follow up out to 12 months post procedure</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>GORE® BIO-A® Fistula Plug</title>
          <description>All patients in study receive the GORE® BIO-A® Fistula Plug.
Fistula Plug: Bioabsorbable fistula plug</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="93"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="45" subjects_at_risk="93"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Extrusion</sub_title>
                <counts group_id="E1" events="16" subjects_affected="6" subjects_at_risk="93"/>
              </event>
              <event>
                <sub_title>Unresolved Fistula</sub_title>
                <counts group_id="E1" events="12" subjects_affected="7" subjects_at_risk="93"/>
              </event>
              <event>
                <sub_title>Other</sub_title>
                <counts group_id="E1" events="56" subjects_affected="25" subjects_at_risk="93"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="15" subjects_affected="7" subjects_at_risk="93"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Michael J Stamos, MD</name_or_title>
      <organization>University of California, Irvine</organization>
      <phone>888-532-4123</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

